KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF

Clinical trial NCT04640532 · UNKNOWN

Trial details

NCT number: NCT04640532
Sponsor: Kartos Therapeutics, Inc.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelofibrosis Post-PV MF Post-ET Myelofibrosis Primary Myelofibrosis

Start date: 2020-11-17
Primary completion: 2022-05-11
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.